It has been reported that knockdown of ERRα in vitro and in vivo significantly inhibits the growth of estrogen receptor-positive (ER+) and triple-negative breast cancer (TNBC) cells [21,26,27,28,29]. Here, ESRRA is linked to triple-negative breast carcinoma.